Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 13

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 13
---
, as nearly as possible, each class will consist of one-third of the directors. The division of our Board into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control of our Company. Our directors may be removed only for cause by the affirmative vote of the holders of at least two-thirds of our outstanding voting stock entitled to vote in the election of directors.

There are no family relationships among any of our executive officers or directors.

If you submit a proxy but do not indicate any voting instructions, the persons named as proxies will vote the shares of Common Stock represented thereby for the election as Class III Directors of the persons whose names and biographies appear below. All of the persons whose names and biographies appear below are currently serving as our directors. In the event any of the nominees should become unable to serve, or for good cause will not serve, as a director, it is intended that votes will be cast for a substitute nominee designated by the Board or the Board may elect to reduce its size. The Board has no reason to believe that the nominees named below will be unable to serve if elected. Each of the nominees has consented to being named in this proxy statement and to serve if elected.

#### Vote Required
This proposal requires the approval of a plurality of the votes cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Class III Directors. Votes withheld and broker non-votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal.

#### Recommendation of the Board
The Board unanimously recommends a vote “FOR” the election of each of the below Class III Director nominees.

<div align='center'>7</div>

Nominees for Class III Directors ( Terms to Expire at 2028 Annual Meeting of Stockholders)

The current members of the Board who have been nominated by the Board for election as Class III Directors are as follows:

| Name                          |     | Age |     | Served as a Director Since |     | Position(s) with Cartesian                      |
| Timothy C. Barabe, M.B.A.     |     |  72 |     |                       2016 |     | Director                                        |
| Carsten Brunn, Ph.D.          |     |  54 |     |                       2018 |     | President and Chief Executive Officer, Director |
| Nishan de Silva, M.D., M.B.A. |